Thyroid Cancer Clinical Trial
Official title:
Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy
Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 30, 2018 |
Est. primary completion date | June 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Patients with maximum tumor diameter =1 cm; 2. patients without lateral neck lymph node metastases; 3. patients without distant metastases; 4. patients who only needed unilateral surgery following the guidelines; 5. patients with strong cosmetic requirement. Exclusion criteria: 1. Patients with maximum tumor diameter >1 cm; 2. patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases; 3. patients without cosmetic requirements. |
Country | Name | City | State |
---|---|---|---|
China | Wen-xin ZHAO | Fuzhou | Fujian |
Lead Sponsor | Collaborator |
---|---|
Bo Wang,MD |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Flap separation time | Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space. | 1 day after surgery | |
Primary | Glandular excision time | Glandular excision time was defined from incising cervical white line to removing Berry ligament. | 1 day after surgery | |
Primary | Central lymph node dissection time | Central lymph node dissection time: was from separating central lymph node to the specimen removed. | 1 day after surgery | |
Secondary | Times of wiping lens | Times of wiping lens calculated from endoscopic video after operation was defined the times of wiping lens from endoscopy into the body to central lymph node removed. | 1 day after surgery | |
Secondary | Volume of intraoperative blood loss | Volume of intraoperative blood loss was estimated the volume of intraoperative blood loss. | 1 day after surgery | |
Secondary | Volume of Postoperative drainage | Volume of Postoperative drainage was accurately calculated the total volume while the drainage tube removed after operation. | 1 day,2 day,3 day after surgery | |
Secondary | The number of identifying parathyroid glands | The number of identifying parathyroid glands was evaluated at postoperation while parathyroid glands was identified during surgery. | 1 day after surgery | |
Secondary | Blood PTH level | measurement of PTH level in blood | preoperative, first day after operation, one week after surgery, two months after surgery. | |
Secondary | Blood calcium level | to measure the blood calcium level in the blood | before surgery, the first day after surgery, one week after surgery, two months after surgery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
Withdrawn |
NCT04224792 -
Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors
|
N/A | |
Completed |
NCT01728623 -
A Study of E7080 in Subjects With Advanced Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT02911155 -
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Not yet recruiting |
NCT03978351 -
The Role of Midkine in Diagnosis of Thyroid Cancer
|
||
Completed |
NCT02658513 -
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
|
||
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Withdrawn |
NCT01994200 -
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
|
Phase 1/Phase 2 | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Terminated |
NCT01403324 -
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
|
N/A | |
Completed |
NCT00970359 -
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
|
N/A | |
Completed |
NCT00439478 -
Dental Safety Profile of High-Dose Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT00223158 -
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
|
N/A | |
Active, not recruiting |
NCT04544111 -
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
|
Phase 2 | |
Completed |
NCT04876287 -
Salivary dysfuncTion After Radioiodine Treatment
|
||
Recruiting |
NCT06073223 -
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
|
N/A | |
Recruiting |
NCT06037174 -
Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery
|
||
Recruiting |
NCT04952493 -
Anlotinib or Penpulimab in Combination With RAI for DTC
|
Phase 2 |